| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 7.46e-08 | 35 | 125 | 6 | GO:0015020 | |
| GeneOntologyMolecularFunction | UDP-glycosyltransferase activity | 5.06e-05 | 153 | 125 | 7 | GO:0008194 | |
| GeneOntologyMolecularFunction | calcium ion binding | NID2 PCDHA9 PCDHA7 DLK1 CHORDC1 ITGB1 LRP1B SVEP1 TBC1D9 ACAN VCAN TNFAIP6 ADGRE1 PCDHGC3 AGRN | 6.99e-05 | 749 | 125 | 15 | GO:0005509 |
| GeneOntologyMolecularFunction | 3'-5' DNA helicase activity | 1.26e-04 | 16 | 125 | 3 | GO:0043138 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | XRN2 ZGRF1 POLG DCP2 VARS2 DARS2 BLM HARS2 FBH1 ASCC3 TOP1MT TOP3A REV1 | 2.05e-04 | 645 | 125 | 13 | GO:0140640 |
| GeneOntologyMolecularFunction | isomerase activity | 2.09e-04 | 192 | 125 | 7 | GO:0016853 | |
| GeneOntologyMolecularFunction | 5'-3' RNA exonuclease activity | 2.31e-04 | 4 | 125 | 2 | GO:0004534 | |
| GeneOntologyMolecularFunction | DNA topoisomerase type I (single strand cut, ATP-independent) activity | 2.31e-04 | 4 | 125 | 2 | GO:0003917 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 2.48e-04 | 262 | 125 | 8 | GO:0140097 | |
| GeneOntologyMolecularFunction | hexosyltransferase activity | 3.70e-04 | 211 | 125 | 7 | GO:0016758 | |
| GeneOntologyMolecularFunction | integrin binding involved in cell-matrix adhesion | 3.84e-04 | 5 | 125 | 2 | GO:0098640 | |
| GeneOntologyMolecularFunction | glycosyltransferase activity | 4.66e-04 | 288 | 125 | 8 | GO:0016757 | |
| GeneOntologyMolecularFunction | DNA helicase activity | 6.17e-04 | 62 | 125 | 4 | GO:0003678 | |
| GeneOntologyMolecularFunction | hyaluronic acid binding | 7.77e-04 | 29 | 125 | 3 | GO:0005540 | |
| GeneOntologyMolecularFunction | DNA topoisomerase activity | 1.06e-03 | 8 | 125 | 2 | GO:0003916 | |
| GeneOntologyMolecularFunction | cell-matrix adhesion mediator activity | 1.36e-03 | 9 | 125 | 2 | GO:0098634 | |
| GeneOntologyMolecularFunction | fibronectin binding | 1.72e-03 | 38 | 125 | 3 | GO:0001968 | |
| GeneOntologyMolecularFunction | carbon-oxygen lyase activity | 1.76e-03 | 82 | 125 | 4 | GO:0016835 | |
| GeneOntologyMolecularFunction | ligase activity, forming carbon-oxygen bonds | 2.30e-03 | 42 | 125 | 3 | GO:0016875 | |
| GeneOntologyMolecularFunction | aminoacyl-tRNA ligase activity | 2.30e-03 | 42 | 125 | 3 | GO:0004812 | |
| GeneOntologyBiologicalProcess | cellular glucuronidation | 2.55e-09 | 21 | 128 | 6 | GO:0052695 | |
| GeneOntologyBiologicalProcess | glucuronate metabolic process | 1.06e-08 | 26 | 128 | 6 | GO:0019585 | |
| GeneOntologyBiologicalProcess | uronic acid metabolic process | 1.06e-08 | 26 | 128 | 6 | GO:0006063 | |
| GeneOntologyBiologicalProcess | biphenyl catabolic process | 9.72e-08 | 8 | 128 | 4 | GO:0070980 | |
| GeneOntologyBiologicalProcess | biphenyl metabolic process | 2.89e-07 | 10 | 128 | 4 | GO:0018879 | |
| GeneOntologyBiologicalProcess | xenobiotic glucuronidation | 6.74e-07 | 12 | 128 | 4 | GO:0052697 | |
| GeneOntologyBiologicalProcess | DNA conformation change | 2.65e-05 | 94 | 128 | 6 | GO:0071103 | |
| GeneOntologyBiologicalProcess | regulation of axon guidance | 4.93e-05 | 12 | 128 | 3 | GO:1902667 | |
| GeneOntologyBiologicalProcess | benzene-containing compound metabolic process | 7.97e-05 | 37 | 128 | 4 | GO:0042537 | |
| GeneOntologyBiologicalProcess | xenobiotic catabolic process | 7.97e-05 | 37 | 128 | 4 | GO:0042178 | |
| GeneOntologyBiologicalProcess | androgen metabolic process | 8.87e-05 | 38 | 128 | 4 | GO:0008209 | |
| GeneOntologyCellularComponent | nuclear outer membrane | 9.72e-05 | 40 | 126 | 4 | GO:0005640 | |
| GeneOntologyCellularComponent | RecQ family helicase-topoisomerase III complex | 2.15e-04 | 4 | 126 | 2 | GO:0031422 | |
| GeneOntologyCellularComponent | DNA helicase complex | 3.56e-04 | 5 | 126 | 2 | GO:0033202 | |
| HumanPheno | EMG: slow motor conduction | 3.49e-06 | 5 | 37 | 3 | HP:0100287 | |
| HumanPheno | Neck flexor weakness | 1.69e-05 | 46 | 37 | 5 | HP:0003722 | |
| Domain | UDPGT | 2.13e-07 | 21 | 123 | 5 | PF00201 | |
| Domain | UDPGT | 2.13e-07 | 21 | 123 | 5 | PS00375 | |
| Domain | UDP_glucos_trans | 2.13e-07 | 21 | 123 | 5 | IPR002213 | |
| Domain | EGF_CA | 1.62e-05 | 122 | 123 | 7 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.80e-05 | 124 | 123 | 7 | IPR001881 | |
| Domain | Sushi | 2.32e-05 | 52 | 123 | 5 | PF00084 | |
| Domain | CCP | 2.79e-05 | 54 | 123 | 5 | SM00032 | |
| Domain | ZnF_C2HC | 3.05e-05 | 55 | 123 | 5 | SM00343 | |
| Domain | Znf_CCHC | 3.05e-05 | 55 | 123 | 5 | IPR001878 | |
| Domain | SUSHI | 3.33e-05 | 56 | 123 | 5 | PS50923 | |
| Domain | Sushi_SCR_CCP_dom | 3.63e-05 | 57 | 123 | 5 | IPR000436 | |
| Domain | Zn_knuckle_CX2CX3GHX4C | 4.30e-05 | 2 | 123 | 2 | IPR025829 | |
| Domain | zf-CCHC_2 | 4.30e-05 | 2 | 123 | 2 | PF13696 | |
| Domain | ASX_HYDROXYL | 5.19e-05 | 100 | 123 | 6 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 7.20e-05 | 106 | 123 | 6 | IPR000152 | |
| Domain | ZF_CCHC | 8.01e-05 | 35 | 123 | 4 | PS50158 | |
| Domain | Topo_IA_cen_sub2 | 1.29e-04 | 3 | 123 | 2 | IPR013825 | |
| Domain | EGF | 1.66e-04 | 235 | 123 | 8 | SM00181 | |
| Domain | EGF | 1.87e-04 | 126 | 123 | 6 | PF00008 | |
| Domain | EGF-like_dom | 2.46e-04 | 249 | 123 | 8 | IPR000742 | |
| Domain | EGF-like_CS | 3.37e-04 | 261 | 123 | 8 | IPR013032 | |
| Domain | EGF_Ca-bd_CS | 4.54e-04 | 97 | 123 | 5 | IPR018097 | |
| Domain | EGF_CA | 4.98e-04 | 99 | 123 | 5 | PS01187 | |
| Domain | - | ZNF449 FEZF2 ZNF674 ZNF316 ZKSCAN2 ZNF57 ZNF835 ZXDB ZSCAN29 ZNF677 ZNF33A FIZ1 ZNF81 | 5.40e-04 | 679 | 123 | 13 | 3.30.160.60 |
| Domain | ZINC_FINGER_C2H2_2 | ZNF449 ZNF609 FEZF2 ZNF674 ZNF316 ZKSCAN2 ZNF57 ZNF835 ZXDB ZSCAN29 ZNF677 ZNF33A FIZ1 ZNF81 | 5.84e-04 | 775 | 123 | 14 | PS50157 |
| Domain | Growth_fac_rcpt_ | 5.87e-04 | 156 | 123 | 6 | IPR009030 | |
| Domain | ZINC_FINGER_C2H2_1 | ZNF449 ZNF609 FEZF2 ZNF674 ZNF316 ZKSCAN2 ZNF57 ZNF835 ZXDB ZSCAN29 ZNF677 ZNF33A FIZ1 ZNF81 | 5.99e-04 | 777 | 123 | 14 | PS00028 |
| Domain | cEGF | 6.49e-04 | 26 | 123 | 3 | PF12662 | |
| Domain | cEGF | 6.49e-04 | 26 | 123 | 3 | IPR026823 | |
| Domain | - | 6.49e-04 | 26 | 123 | 3 | 4.10.60.10 | |
| Domain | zf-C2H2 | ZNF449 FEZF2 ZNF674 ZNF316 ZKSCAN2 ZNF57 ZNF835 ZXDB ZSCAN29 ZNF677 ZNF33A FIZ1 ZNF81 | 6.53e-04 | 693 | 123 | 13 | PF00096 |
| Domain | EGF_extracell | 6.57e-04 | 60 | 123 | 4 | IPR013111 | |
| Domain | EGF_2 | 6.57e-04 | 60 | 123 | 4 | PF07974 | |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF449 FEZF2 ZNF674 ZNF316 ZKSCAN2 ZNF57 ZNF835 ZXDB ZSCAN29 ZNF677 ZNF33A FIZ1 ZNF81 | 6.62e-04 | 694 | 123 | 13 | IPR013087 |
| Domain | Znf_C2H2-like | ZNF449 ZNF609 FEZF2 ZNF674 ZNF316 ZKSCAN2 ZNF57 ZNF835 ZXDB ZSCAN29 ZNF677 ZNF33A FIZ1 ZNF81 | 7.59e-04 | 796 | 123 | 14 | IPR015880 |
| Domain | Znf_C2H2 | ZNF449 ZNF609 FEZF2 ZNF674 ZNF316 ZKSCAN2 ZNF57 ZNF835 ZXDB ZSCAN29 ZNF677 ZNF33A FIZ1 ZNF81 | 8.46e-04 | 805 | 123 | 14 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF449 ZNF609 FEZF2 ZNF674 ZNF316 ZKSCAN2 ZNF57 ZNF835 ZXDB ZSCAN29 ZNF677 ZNF33A FIZ1 ZNF81 | 8.77e-04 | 808 | 123 | 14 | SM00355 |
| Domain | Znf_GRF | 8.84e-04 | 7 | 123 | 2 | IPR010666 | |
| Domain | zf-GRF | 8.84e-04 | 7 | 123 | 2 | PF06839 | |
| Domain | EGF_3 | 9.42e-04 | 235 | 123 | 7 | PS50026 | |
| Domain | EGF_1 | 1.51e-03 | 255 | 123 | 7 | PS00022 | |
| Domain | Cadherin_tail | 1.84e-03 | 37 | 123 | 3 | PF15974 | |
| Domain | Cadherin_CBD | 1.84e-03 | 37 | 123 | 3 | IPR031904 | |
| Domain | EGF_2 | 1.88e-03 | 265 | 123 | 7 | PS01186 | |
| Domain | Filamin | 2.28e-03 | 11 | 123 | 2 | PF00630 | |
| Domain | Fol_N | 2.28e-03 | 11 | 123 | 2 | IPR003645 | |
| Domain | GFP-like | 2.28e-03 | 11 | 123 | 2 | IPR023413 | |
| Domain | FILAMIN_REPEAT | 2.28e-03 | 11 | 123 | 2 | PS50194 | |
| Domain | Filamin/ABP280_rpt | 2.28e-03 | 11 | 123 | 2 | IPR001298 | |
| Domain | Filamin/ABP280_repeat-like | 2.28e-03 | 11 | 123 | 2 | IPR017868 | |
| Domain | - | 2.28e-03 | 11 | 123 | 2 | 2.40.155.10 | |
| Domain | FOLN | 2.28e-03 | 11 | 123 | 2 | SM00274 | |
| Domain | EGF_CA | 2.51e-03 | 86 | 123 | 4 | PF07645 | |
| Domain | Cadherin_C | 2.65e-03 | 42 | 123 | 3 | IPR032455 | |
| Domain | Cadherin_C_2 | 2.65e-03 | 42 | 123 | 3 | PF16492 | |
| Domain | KRAB | 3.09e-03 | 369 | 123 | 8 | SM00349 | |
| Domain | KRAB | 3.14e-03 | 370 | 123 | 8 | IPR001909 | |
| Domain | Link_dom | 3.20e-03 | 13 | 123 | 2 | IPR000538 | |
| Domain | Xlink | 3.20e-03 | 13 | 123 | 2 | PF00193 | |
| Domain | LINK_2 | 3.20e-03 | 13 | 123 | 2 | PS50963 | |
| Domain | LINK | 3.20e-03 | 13 | 123 | 2 | SM00445 | |
| Domain | LINK_1 | 3.20e-03 | 13 | 123 | 2 | PS01241 | |
| Domain | Ldl_recept_b | 3.72e-03 | 14 | 123 | 2 | PF00058 | |
| Domain | LDLRB | 3.72e-03 | 14 | 123 | 2 | PS51120 | |
| Domain | CUB | 4.12e-03 | 49 | 123 | 3 | PF00431 | |
| Domain | LY | 4.27e-03 | 15 | 123 | 2 | SM00135 | |
| Domain | LDLR_classB_rpt | 4.27e-03 | 15 | 123 | 2 | IPR000033 | |
| Domain | CUB | 4.36e-03 | 50 | 123 | 3 | SM00042 | |
| Domain | - | 4.87e-03 | 52 | 123 | 3 | 2.60.120.290 | |
| Domain | CUB | 5.14e-03 | 53 | 123 | 3 | PS01180 | |
| Domain | - | 5.48e-03 | 17 | 123 | 2 | 4.10.800.10 | |
| Domain | Thyroglobulin_1 | 5.48e-03 | 17 | 123 | 2 | IPR000716 | |
| Domain | THYROGLOBULIN_1_1 | 5.48e-03 | 17 | 123 | 2 | PS00484 | |
| Domain | TY | 5.48e-03 | 17 | 123 | 2 | SM00211 | |
| Domain | THYROGLOBULIN_1_2 | 5.48e-03 | 17 | 123 | 2 | PS51162 | |
| Domain | Thyroglobulin_1 | 5.48e-03 | 17 | 123 | 2 | PF00086 | |
| Domain | SCAN | 5.99e-03 | 56 | 123 | 3 | SM00431 | |
| Domain | aa-tRNA-synth_II | 6.14e-03 | 18 | 123 | 2 | IPR006195 | |
| Domain | AA_TRNA_LIGASE_II | 6.14e-03 | 18 | 123 | 2 | PS50862 | |
| Domain | CUB_dom | 6.30e-03 | 57 | 123 | 3 | IPR000859 | |
| Pathway | REACTOME_GLUCURONIDATION | 3.17e-09 | 24 | 79 | 6 | MM14599 | |
| Pathway | REACTOME_GLUCURONIDATION | 4.15e-09 | 25 | 79 | 6 | M17787 | |
| Pathway | WP_GLUCURONIDATION | 4.15e-09 | 25 | 79 | 6 | MM15820 | |
| Pathway | WP_GLUCURONIDATION | 5.38e-09 | 26 | 79 | 6 | M39404 | |
| Pathway | KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM | 9.82e-08 | 41 | 79 | 6 | M7399 | |
| Pathway | REACTOME_ASPIRIN_ADME | 1.52e-07 | 44 | 79 | 6 | M45014 | |
| Pathway | REACTOME_ASPIRIN_ADME | 1.75e-07 | 45 | 79 | 6 | MM15694 | |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | 2.37e-07 | 25 | 79 | 5 | M605 | |
| Pathway | KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS | 4.32e-07 | 28 | 79 | 5 | M19580 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 2.97e-06 | 72 | 79 | 6 | M9257 | |
| Pathway | REACTOME_PREDNISONE_ADME | 7.46e-06 | 23 | 79 | 4 | MM16639 | |
| Pathway | KEGG_DRUG_METABOLISM_OTHER_ENZYMES | 9.34e-06 | 51 | 79 | 5 | M17726 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 1.03e-05 | 52 | 79 | 5 | M14171 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | 1.36e-05 | 55 | 79 | 5 | M14933 | |
| Pathway | KEGG_RETINOL_METABOLISM | 2.86e-05 | 64 | 79 | 5 | M9488 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 2.95e-05 | 107 | 79 | 6 | MM14595 | |
| Pathway | REACTOME_DRUG_ADME | 3.27e-05 | 109 | 79 | 6 | M45012 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 3.27e-05 | 109 | 79 | 6 | M18788 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 4.43e-05 | 70 | 79 | 5 | M16794 | |
| Pathway | REACTOME_DRUG_ADME | 5.36e-05 | 119 | 79 | 6 | MM15692 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 6.47e-05 | 39 | 79 | 4 | MM15695 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 1.36e-04 | 47 | 79 | 4 | MM14925 | |
| Pathway | REACTOME_MITOCHONDRIAL_TRNA_AMINOACYLATION | 2.09e-04 | 21 | 79 | 3 | M15096 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 2.23e-04 | 219 | 79 | 7 | MM14838 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 2.29e-04 | 220 | 79 | 7 | M10320 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II | 5.59e-04 | 183 | 79 | 6 | M39588 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 5.98e-04 | 258 | 79 | 7 | MM14572 | |
| Pathway | WP_COVID19_THROMBOSIS_AND_ANTICOAGULATION | 6.39e-04 | 7 | 79 | 2 | M39868 | |
| Pathway | WP_TRYPTOPHAN_METABOLISM | 8.19e-04 | 33 | 79 | 3 | M39500 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 8.63e-04 | 76 | 79 | 4 | M27219 | |
| Pathway | REACTOME_CHL1_INTERACTIONS | 1.09e-03 | 9 | 79 | 2 | M27379 | |
| Pathway | REACTOME_DIFFERENTIATION_OF_KERATINOCYTES_IN_INTERFOLLICULAR_EPIDERMIS_IN_MAMMALIAN_SKIN | 1.44e-03 | 40 | 79 | 3 | M48231 | |
| Pathway | KEGG_TRYPTOPHAN_METABOLISM | 1.44e-03 | 40 | 79 | 3 | M980 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.44e-03 | 300 | 79 | 7 | M610 | |
| Pathway | KEGG_AMINOACYL_TRNA_BIOSYNTHESIS | 1.55e-03 | 41 | 79 | 3 | M14691 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_GLYCOSAMINOGLYCAN_METABOLISM | 1.55e-03 | 41 | 79 | 3 | M27257 | |
| Pathway | REACTOME_TRNA_AMINOACYLATION | 1.66e-03 | 42 | 79 | 3 | M456 | |
| Pathway | WP_IRON_METABOLISM_IN_PLACENTA | 1.97e-03 | 12 | 79 | 2 | M39660 | |
| Pubmed | 6.07e-09 | 7 | 128 | 4 | 26074487 | ||
| Pubmed | 1.21e-08 | 8 | 128 | 4 | 32093886 | ||
| Pubmed | 1.21e-08 | 8 | 128 | 4 | 10748067 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | FLNC DMXL2 XRN2 MYCBP2 RBBP6 SF1 ZSCAN29 BLM RBM25 ZC2HC1A GTF3C1 VCAN WDR82 POLDIP2 PPIP5K2 GCN1 AGRN | 5.08e-07 | 1082 | 128 | 17 | 38697112 |
| Pubmed | UBR1 DMXL2 XRN2 ZNF609 ZXDB NRP1 GTF3C1 PRKCI POLDIP2 PPIP5K2 PCDHGC3 AGRN TOP3A | 8.94e-07 | 650 | 128 | 13 | 38777146 | |
| Pubmed | 2.69e-06 | 8 | 128 | 3 | 18719240 | ||
| Pubmed | 4.66e-06 | 66 | 128 | 5 | 19898482 | ||
| Pubmed | Loss of nidogen-1 and -2 results in syndactyly and changes in limb development. | 7.86e-06 | 11 | 128 | 3 | 17023412 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ZNF449 ENOSF1 GALNT10 ZNF609 MYCBP2 ATXN7L1 POLG WDR25 STK32C ITGB1 NRP1 CFAP20DC ZNF33A GTF3C1 PRKCI MMP16 WNK2 PDZD2 | 9.15e-06 | 1489 | 128 | 18 | 28611215 |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 10222050 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 19440389 | ||
| Pubmed | Two type I topoisomerases maintain DNA topology in human mitochondria. | 1.34e-05 | 2 | 128 | 2 | 36215039 | |
| Pubmed | Tensin 2 modulates cell contractility in 3D collagen gels through the RhoGAP DLC1. | 1.34e-05 | 2 | 128 | 2 | 20069572 | |
| Pubmed | Identification and characterization of versican/PG-M aggregates in cartilage. | 1.34e-05 | 2 | 128 | 2 | 16648631 | |
| Pubmed | Association of the Bloom syndrome protein with topoisomerase IIIalpha in somatic and meiotic cells. | 1.34e-05 | 2 | 128 | 2 | 10728666 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 11932252 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 17263731 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 29750423 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 9654129 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 15319348 | ||
| Pubmed | Evidence for BLM and Topoisomerase IIIalpha interaction in genomic stability. | 1.34e-05 | 2 | 128 | 2 | 11406610 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 11805102 | ||
| Pubmed | Plasminogen binds the heparin-binding domain of insulin-like growth factor-binding protein-3. | 1.34e-05 | 2 | 128 | 2 | 9688635 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 17726369 | ||
| Pubmed | The Bloom's syndrome gene product interacts with topoisomerase III. | 1.34e-05 | 2 | 128 | 2 | 10734115 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 11467860 | ||
| Pubmed | The Bloom's syndrome helicase stimulates the activity of human topoisomerase IIIalpha. | 1.34e-05 | 2 | 128 | 2 | 12433984 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 26540630 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 9337997 | ||
| Pubmed | The UGT2A1/UGT2A2 locus is associated with COVID-19-related loss of smell or taste. | 1.34e-05 | 2 | 128 | 2 | 35039640 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 22645138 | ||
| Pubmed | START-GAP1/DLC1 is localized in focal adhesions through interaction with the PTB domain of tensin2. | 1.34e-05 | 2 | 128 | 2 | 19895840 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 11376859 | ||
| Pubmed | Collaborating functions of BLM and DNA topoisomerase I in regulating human rDNA transcription. | 1.34e-05 | 2 | 128 | 2 | 23261817 | |
| Pubmed | Cloning and characterization of a novel human olfactory UDP-glucuronosyltransferase. | 1.34e-05 | 2 | 128 | 2 | 10359671 | |
| Pubmed | Congenital dyserythropoietic anemia type I is caused by mutations in codanin-1. | 1.36e-05 | 13 | 128 | 3 | 12434312 | |
| Pubmed | Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche. | 1.97e-05 | 149 | 128 | 6 | 25231870 | |
| Pubmed | 2.60e-05 | 418 | 128 | 9 | 34709266 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | UBR1 XRN2 WASHC2C MYCBP2 RBBP6 SF1 TBC1D9 BLM RBM25 KMT2D GTF3C1 PROSER2 | 3.05e-05 | 774 | 128 | 12 | 15302935 |
| Pubmed | 3.19e-05 | 17 | 128 | 3 | 28634350 | ||
| Pubmed | 3.54e-05 | 50 | 128 | 4 | 23658023 | ||
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | MYCBP2 POLG SPTLC1 VARS2 NUDT8 ITGB1 SF1 DARS2 ATL1 BLM NBAS HARS2 NFX1 PRKCI HADH POLDIP2 TOP3A | 3.62e-05 | 1496 | 128 | 17 | 32877691 |
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 10825162 | ||
| Pubmed | Link protein has greater affinity for versican than aggrecan. | 4.02e-05 | 3 | 128 | 2 | 14724283 | |
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 19669783 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 15590670 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 8333863 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 29138287 | ||
| Pubmed | Association between polymorphisms in RMI1, TOP3A, and BLM and risk of cancer, a case-control study. | 4.02e-05 | 3 | 128 | 2 | 19432957 | |
| Pubmed | Holliday junction processing activity of the BLM-Topo IIIalpha-BLAP75 complex. | 4.02e-05 | 3 | 128 | 2 | 17728255 | |
| Pubmed | Structural Basis of Diverse Homophilic Recognition by Clustered α- and β-Protocadherins. | 4.02e-05 | 3 | 128 | 2 | 27161523 | |
| Pubmed | BLAP75/RMI1 promotes the BLM-dependent dissolution of homologous recombination intermediates. | 4.02e-05 | 3 | 128 | 2 | 16537486 | |
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 28377405 | ||
| Pubmed | Fibulin-1 is a ligand for the C-type lectin domains of aggrecan and versican. | 4.02e-05 | 3 | 128 | 2 | 10400671 | |
| Pubmed | Human topoisomerase IIIalpha is a single-stranded DNA decatenase that is stimulated by BLM and RMI1. | 4.02e-05 | 3 | 128 | 2 | 20445207 | |
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 9808625 | ||
| Pubmed | Distinct interaction of versican/PG-M with hyaluronan and link protein. | 4.02e-05 | 3 | 128 | 2 | 12888576 | |
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 7835904 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 14620382 | ||
| Pubmed | A double Holliday junction dissolvasome comprising BLM, topoisomerase IIIalpha, and BLAP75. | 4.02e-05 | 3 | 128 | 2 | 16595695 | |
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 26801741 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 23756265 | ||
| Pubmed | Massive aggrecan and versican accumulation in thoracic aortic aneurysm and dissection. | 4.02e-05 | 3 | 128 | 2 | 29515038 | |
| Pubmed | Functional role of BLAP75 in BLM-topoisomerase IIIalpha-dependent holliday junction processing. | 4.02e-05 | 3 | 128 | 2 | 18390547 | |
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 16951145 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 19858781 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 22092298 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 15642732 | ||
| Pubmed | 4.90e-05 | 257 | 128 | 7 | 16335952 | ||
| Pubmed | 8.02e-05 | 4 | 128 | 2 | 7538844 | ||
| Pubmed | Crystal structures of RMI1 and RMI2, two OB-fold regulatory subunits of the BLM complex. | 8.02e-05 | 4 | 128 | 2 | 20826342 | |
| Pubmed | 8.02e-05 | 4 | 128 | 2 | 16849011 | ||
| Pubmed | 8.02e-05 | 4 | 128 | 2 | 20554254 | ||
| Pubmed | 8.02e-05 | 4 | 128 | 2 | 24887021 | ||
| Pubmed | 8.02e-05 | 4 | 128 | 2 | 10218588 | ||
| Pubmed | 8.02e-05 | 4 | 128 | 2 | 10024527 | ||
| Pubmed | 8.02e-05 | 4 | 128 | 2 | 11470874 | ||
| Pubmed | Duplex DNA and BLM regulate gate opening by the human TopoIIIα-RMI1-RMI2 complex. | 8.02e-05 | 4 | 128 | 2 | 35102151 | |
| Pubmed | The integrin ligand SVEP1 regulates GPCR-mediated vasoconstriction via integrins α9β1 and α4β1. | 8.02e-05 | 4 | 128 | 2 | 35802072 | |
| Pubmed | 8.02e-05 | 4 | 128 | 2 | 24984776 | ||
| Pubmed | 8.02e-05 | 4 | 128 | 2 | 10766023 | ||
| Pubmed | 8.02e-05 | 4 | 128 | 2 | 8843739 | ||
| Pubmed | 8.02e-05 | 4 | 128 | 2 | 21584905 | ||
| Pubmed | BLAP75, an essential component of Bloom's syndrome protein complexes that maintain genome integrity. | 8.02e-05 | 4 | 128 | 2 | 15775963 | |
| Pubmed | Lupus nephritis susceptibility loci in women with systemic lupus erythematosus. | 8.17e-05 | 23 | 128 | 3 | 24925725 | |
| Pubmed | 9.31e-05 | 24 | 128 | 3 | 24698270 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | ZNF609 WASHC2C DCP2 HJURP CHORDC1 BLM NBAS TTBK2 GTF3C1 WDR82 PRKCI GCN1 TOP3A WDTC1 | 9.47e-05 | 1155 | 128 | 14 | 20360068 |
| Pubmed | 1.33e-04 | 5 | 128 | 2 | 11038354 | ||
| Pubmed | Talin1 regulates integrin turnover to promote embryonic epithelial morphogenesis. | 1.33e-04 | 5 | 128 | 2 | 21670148 | |
| Pubmed | 1.33e-04 | 5 | 128 | 2 | 17190795 | ||
| Pubmed | 1.33e-04 | 5 | 128 | 2 | 22654117 | ||
| Pubmed | Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily. | 1.33e-04 | 5 | 128 | 2 | 16141793 | |
| Pubmed | 1.33e-04 | 5 | 128 | 2 | 23543748 | ||
| Pubmed | 1.33e-04 | 5 | 128 | 2 | 24108125 | ||
| Pubmed | 1.33e-04 | 5 | 128 | 2 | 34888534 | ||
| Pubmed | 1.33e-04 | 5 | 128 | 2 | 15318931 | ||
| Pubmed | 1.33e-04 | 5 | 128 | 2 | 15090462 | ||
| Pubmed | 1.33e-04 | 5 | 128 | 2 | 20711169 | ||
| Pubmed | Interaction with protocadherin-gamma regulates the cell surface expression of protocadherin-alpha. | 1.49e-04 | 28 | 128 | 3 | 15347688 | |
| Pubmed | 1.66e-04 | 29 | 128 | 3 | 22613833 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q13 | 5.59e-06 | 157 | 128 | 6 | chr4q13 | |
| Cytoband | 4q13 | 9.40e-06 | 15 | 128 | 3 | 4q13 | |
| Cytoband | 10p11.2 | 2.14e-04 | 8 | 128 | 2 | 10p11.2 | |
| GeneFamily | UDP glucuronosyltransferases | 5.96e-09 | 32 | 82 | 6 | 363 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 2.18e-07 | 57 | 82 | 6 | 1179 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF449 ZNF609 FEZF2 ZNF674 ZNF316 ZKSCAN2 ZNF57 ZNF835 ZXDB ZSCAN29 ZNF677 ZNF33A FIZ1 ZNF81 | 3.84e-06 | 718 | 82 | 14 | 28 |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 1.21e-04 | 4 | 82 | 2 | 574 | |
| GeneFamily | Topoisomerases | 3.01e-04 | 6 | 82 | 2 | 1050 | |
| GeneFamily | Zinc fingers GRF-type|Topoisomerases | 4.20e-04 | 7 | 82 | 2 | 135 | |
| GeneFamily | DNA helicases | 2.64e-03 | 17 | 82 | 2 | 1167 | |
| GeneFamily | Clustered protocadherins | 3.07e-03 | 64 | 82 | 3 | 20 | |
| GeneFamily | Aminoacyl tRNA synthetases, Class II | 3.30e-03 | 19 | 82 | 2 | 132 | |
| GeneFamily | DNA polymerases | 4.83e-03 | 23 | 82 | 2 | 535 | |
| GeneFamily | Nudix hydrolase family | 5.26e-03 | 24 | 82 | 2 | 667 | |
| GeneFamily | Zinc fingers CCHC-type|RNA binding motif containing | 5.70e-03 | 25 | 82 | 2 | 74 | |
| Coexpression | DESCARTES_ORGANOGENESIS_HEPATOCYTES | HJURP BCORL1 DLK1 ACOT4 F13B CFHR3 CROT UGT2B4 UGT2B7 UGT2B10 HADH UGT2B28 PLG | 2.11e-06 | 535 | 127 | 13 | MM3635 |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.67e-08 | 155 | 128 | 8 | 77fdae85d36efb776db977eb424b32487ef222e4 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.09e-08 | 190 | 128 | 8 | 4f775ee24b14733f06ae40b45f2dc1a0f0df0705 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-5|TCGA-Skin / Sample_Type by Project: Shred V9 | 8.52e-07 | 178 | 128 | 7 | ad5cd505ca1cef8ac29b2af7e2c3e01ebc140c14 | |
| ToppCell | 5'-Adult-LymphNode-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.52e-07 | 181 | 128 | 7 | ab66a89f316b935d9ba1277426d976b1e9e39757 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.46e-06 | 193 | 128 | 7 | adc9fc94f9ec686a417d08c0b8b7b7ab687afec0 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.68e-06 | 197 | 128 | 7 | 2744cc94883c5d0424677cf5093bbab622933e9b | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.79e-06 | 199 | 128 | 7 | 333056c2abe9724efeab542c0365fcfe4eff8f18 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.79e-06 | 199 | 128 | 7 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.79e-06 | 199 | 128 | 7 | e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuroepithelial|6m / Sample Type, Dataset, Time_group, and Cell type. | 1.85e-06 | 200 | 128 | 7 | 2cc98abf11f5b58707de45a2282f03d47f00f035 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.85e-06 | 200 | 128 | 7 | 3dd022e974fec7013ba18f333da63f58fbf2dd7c | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuroepithelial-Proteoglycan-expressing_cell|6m / Sample Type, Dataset, Time_group, and Cell type. | 1.85e-06 | 200 | 128 | 7 | 0f7431f670f3a175377cefae3479403a881bb8fb | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.54e-06 | 169 | 128 | 6 | b6b5bb6408c1305a00719e1b88a5e1202081faf3 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-05 | 171 | 128 | 6 | b0373ed8283ee1792b6a490bff93906546978593 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-05 | 171 | 128 | 6 | b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.28e-05 | 178 | 128 | 6 | 142879e9393e721f9b05a6bb46995c9d6d713c95 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.37e-05 | 180 | 128 | 6 | f8a15c13d85c1bbbf86ce49bb6f86c368ddf22df | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.45e-05 | 182 | 128 | 6 | b7d532feb73167e05475855061b35a209583f44c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.45e-05 | 182 | 128 | 6 | af65f0fc3f9e5d9ce69ee5faaf5b6cb7f8412e0c | |
| ToppCell | facs-Kidney-nan-3m|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-05 | 182 | 128 | 6 | 4c5d14e33ebdf117b5aa9e2f57aaa89aa51f72bf | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neuron_precursor-cycling_neuroblast|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.45e-05 | 182 | 128 | 6 | e6968e0bd9cef92052d04ac54e2dd746b37623f6 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.59e-05 | 185 | 128 | 6 | efc5d564f8793c751ba640aef60f761e4b081d3f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.59e-05 | 185 | 128 | 6 | 30e041d6f6e310d64809e9d6d93cd30052972f3b | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-OPC|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.59e-05 | 185 | 128 | 6 | fba2dc46cd98ab9c78e788959c2121aa10d148b2 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Treg_cell_3|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.69e-05 | 187 | 128 | 6 | 1eed2c1a05e80a7c8f639437c117afe0c18dfb0c | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.69e-05 | 187 | 128 | 6 | a96495803ba13fcfadd1d83b3cf5774f3fed0a20 | |
| ToppCell | 10x5'-GI_large-bowel-Myeloid_Monocytic|GI_large-bowel / Manually curated celltypes from each tissue | 1.75e-05 | 188 | 128 | 6 | d0045fdda757d191dabc7853f6a6e99c0e97d93d | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.75e-05 | 188 | 128 | 6 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | 10x5'-GI_large-bowel-Myeloid_Monocytic-Classical_monocytes|GI_large-bowel / Manually curated celltypes from each tissue | 1.75e-05 | 188 | 128 | 6 | 0bcf04aa47738f43c1a87dae5dc487738ee86f8c | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma-chondrocyte|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.75e-05 | 188 | 128 | 6 | c9270517e6940e9793586f67f02431210552f278 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.80e-05 | 189 | 128 | 6 | 71397e993a77d70b2eeede240bdfc7660b558987 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.80e-05 | 189 | 128 | 6 | 4eea4759520c312bd17a681034d8074e47093d2b | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.85e-05 | 190 | 128 | 6 | 6c7e1086c0a274cd5527c3104106e372811c9905 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.91e-05 | 191 | 128 | 6 | 156b467187331ac6ca390d6ca861d9670bb7b956 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.97e-05 | 192 | 128 | 6 | 5105e4b577408b4e1a62d0a44c23c2b830ccad88 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.97e-05 | 192 | 128 | 6 | d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.03e-05 | 193 | 128 | 6 | cd45118ced91b10baed3b1068d4673ec99824b86 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.09e-05 | 194 | 128 | 6 | 81713e0409e8be695ba5dfdc67a997b33435dd9e | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.09e-05 | 194 | 128 | 6 | 99577a5a631e607b5abe7a1b0d8d6a5eabe50196 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.09e-05 | 194 | 128 | 6 | e03ba6caed59fa64d4d9b042593469d4a6a3dc10 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.09e-05 | 194 | 128 | 6 | 627cffe2d448e74fc5df92e74e5b922a73304137 | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-8|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 2.09e-05 | 194 | 128 | 6 | 55b97095a7a17a312c616703d291738a0f806339 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.15e-05 | 195 | 128 | 6 | 70387a62f121f8c374dba1aca9ab65cfed6a0b10 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.21e-05 | 196 | 128 | 6 | f374cb3ec31c6eef2cef9e07547bfd1e380553af | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.21e-05 | 196 | 128 | 6 | 671c380b58d7f634b4fbec38c357d357ea4f3535 | |
| ToppCell | COVID-19-Epithelial-Club,_Basal_cells|Epithelial / Condition, Lineage and Cell class | 2.27e-05 | 197 | 128 | 6 | 78ed2810e5a765327e7a6da0ca5d4854bf7a0b6f | |
| ToppCell | Mild_COVID-19-Epithelial-Basal/Club|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 2.27e-05 | 197 | 128 | 6 | 4cc5b778e1e2c6c149160fa147c172977c0fa8eb | |
| ToppCell | COVID-19-kidney-Fibroblast-2|kidney / Disease (COVID-19 only), tissue and cell type | 2.34e-05 | 198 | 128 | 6 | ca26ca460856b1faaa3e83766da6abdf63af2b51 | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial|LPS_only / Treatment groups by lineage, cell group, cell type | 2.34e-05 | 198 | 128 | 6 | e035380578c01b0243bfef29ca9b50cc17cce771 | |
| ToppCell | LPS_only-Epithelial_airway|LPS_only / Treatment groups by lineage, cell group, cell type | 2.34e-05 | 198 | 128 | 6 | ba090210392e001a3f7bdf09371b3f0e0c8c7ef3 | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial-Airway-Club|LPS_only / Treatment groups by lineage, cell group, cell type | 2.41e-05 | 199 | 128 | 6 | 165ac94b2d56072ad43358b5127d77555221e2d8 | |
| ToppCell | kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.41e-05 | 199 | 128 | 6 | 174f6013af6eafa577f84205a62927f2b367fda3 | |
| ToppCell | COVID-19-kidney-Fibroblast-1|kidney / Disease (COVID-19 only), tissue and cell type | 2.41e-05 | 199 | 128 | 6 | 9503646ff1ad248181146ce767e9d12e882ec3bd | |
| ToppCell | background-Hepatocytes|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.47e-05 | 200 | 128 | 6 | 423cca10df6ae0489a8fe7e7df87e70364dac022 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Nxph2_Wls|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.71e-05 | 130 | 128 | 5 | 05d5a73acf1d7f75a79876b1a06d27c74a89b8a4 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 4.44e-05 | 135 | 128 | 5 | 3351e8b9e417397c5fa9f856184ff24ce1a27242 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4/8-lo-Trm_Tgd|Liver / Manually curated celltypes from each tissue | 8.30e-05 | 154 | 128 | 5 | c6308074468235c88ef4ea43ab155d9f86cbf261 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-Neutrophil-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.94e-05 | 160 | 128 | 5 | 70f3637dd0bcfcef421aa114f946fff0048f192e | |
| ToppCell | 3'-Airway_Nasal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.02e-04 | 161 | 128 | 5 | 3a5f2877e3b29463a3a6da05009b0ab8747b4c47 | |
| ToppCell | PND07-28-samps-Epithelial-Epithelial-non_alveolar-Club_cell|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.05e-04 | 162 | 128 | 5 | aed15eef32419b8a4e2afdb9776c2bf2802e96f1 | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-04 | 163 | 128 | 5 | 30cd95d4f37bd54c1fde54960cb005db58bdd30c | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-04 | 163 | 128 | 5 | ab934cb986495adfc8dbe5a276577f2a8fb6ee03 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-Goblet_(subsegmental)_L.0.4.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.21e-04 | 167 | 128 | 5 | 31633899aae852873a4887e72c621474b0a51a33 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.25e-04 | 168 | 128 | 5 | 27cdf5cfa1d906868cfd60fdfab3cd51f3b3602f | |
| ToppCell | droplet-Fat-Scat|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-04 | 170 | 128 | 5 | de722bea7527d6ad11b69f8e9589638f52854beb | |
| ToppCell | facs-Marrow-T-cells-3m-Hematologic-MPP_Fraction_B_+_C|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-04 | 170 | 128 | 5 | d70aaa0f4e5034bb9f61b832b5f9123870936d3c | |
| ToppCell | PBMC-Convalescent-Hematopoietic-HSPC-HSPC|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.36e-04 | 171 | 128 | 5 | 2031797d579ce373921affad70da6e50eec13664 | |
| ToppCell | PBMC-Convalescent-Hematopoietic-HSPC-HSPC-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.36e-04 | 171 | 128 | 5 | a4e13b304ef414722ffdc06560deeab41785e956 | |
| ToppCell | PBMC-Convalescent-Hematopoietic-HSPC|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.36e-04 | 171 | 128 | 5 | 172db31a37b72fb87fe5f0f79da51866b90dd1ad | |
| ToppCell | PBMC-Convalescent-Hematopoietic-HSPC-HSPC-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.39e-04 | 172 | 128 | 5 | 8fd3db757d54949bd583d5f0eadf63a32342cb9d | |
| ToppCell | 343B-Fibroblasts-Fibroblast-B_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.39e-04 | 172 | 128 | 5 | c6bc78fd63c9479a84ec0552b55c89750cad0fa5 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-B_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.39e-04 | 172 | 128 | 5 | bfb87a281a9cf6ad45b310bf8104fc0ab382b549 | |
| ToppCell | PBMC-Convalescent-Hematopoietic-HSPC|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.39e-04 | 172 | 128 | 5 | da78f7a71b7f05c5c484c9ed19ba37c55d35e870 | |
| ToppCell | PBMC-Convalescent-Hematopoietic-HSPC-HSPC|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.39e-04 | 172 | 128 | 5 | 382cb5fea099110eb026a8bba6cf4c28763ea52f | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-04 | 173 | 128 | 5 | ca3d2a9562734f76127e3e7d54c10b63e95141bb | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-04 | 173 | 128 | 5 | 19a9e10885173d7712996be8660a3a5a7a9aa39f | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L5-6_FEZF2_ANKRD20A1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.47e-04 | 174 | 128 | 5 | 99eb5e1aee136c7039e23b68a43a0fa3d775859f | |
| ToppCell | TCGA-Colorectal-Recurrent_Tumor|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.51e-04 | 175 | 128 | 5 | 7f74961436f88c0e380819095e6104489914d765 | |
| ToppCell | COVID-19_Severe-Classical_Monocyte-cMono_1|Classical_Monocyte / Disease condition and Cell class | 1.51e-04 | 175 | 128 | 5 | 35ea2ed93538e6bf803029fcf7d9243f93e7733d | |
| ToppCell | TCGA-Colorectal-Recurrent_Tumor-Colorectal_Adenocarcinoma|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.51e-04 | 175 | 128 | 5 | bee8f31f036dfcf9fc6ed29156554771a9ee3c60 | |
| ToppCell | B_cells-pDCs|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 1.55e-04 | 176 | 128 | 5 | ce757de9e09a225f3f96433f103f43619b0e0dda | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.59e-04 | 177 | 128 | 5 | 8220cc2fc0ee8764a67a3be51d75248be2453040 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-04 | 177 | 128 | 5 | 14fb8d182775dfd0e49aa7e4e12543a85b3b8bd6 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.59e-04 | 177 | 128 | 5 | 7617270f49cd6b7ba66db72d20560cee985012b2 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-04 | 178 | 128 | 5 | 78a0c6340001a77f5b2d890b6263f574af2e72da | |
| ToppCell | Adult-Epithelial-lung_goblet_cell|Adult / Lineage, Cell type, age group and donor | 1.68e-04 | 179 | 128 | 5 | 1fc1f252ca943a2f649d1e627f56acbf15f8e058 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_CPZ|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.72e-04 | 180 | 128 | 5 | a499548391e6833b78f6e920f8e32a755814a9da | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.77e-04 | 181 | 128 | 5 | 08f44323bf71b6004a921bbc969c954c75feeb66 | |
| ToppCell | COVID-19_Severe-Classical_Monocyte-cMono_1|COVID-19_Severe / Disease condition and Cell class | 1.77e-04 | 181 | 128 | 5 | 0d07a67e8ee3bca687b378afbc4044434e63556d | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-04 | 181 | 128 | 5 | c6d2a13df3b74fade3b0c71e285b4c14c8e52413 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-04 | 181 | 128 | 5 | c62b0a2422377ffadaab63edd538e87a06fa5017 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-OPC|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.81e-04 | 182 | 128 | 5 | 8a8b08ac4bb3cba3541dbe234e088703842285b9 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.81e-04 | 182 | 128 | 5 | a05e5978ef5f7fac7eeb2ba1c0103ea90d5e9136 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-OPC|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.81e-04 | 182 | 128 | 5 | 831b5ce46b41efe01c4db6016c2f43148611373d | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.81e-04 | 182 | 128 | 5 | 57f8b8d7b132f3ad6f2b1e79c3812fe938657d2c | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-OPC|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.81e-04 | 182 | 128 | 5 | 3cc61f5f7ad4a81eba3daf65e122880b5af3adc0 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.81e-04 | 182 | 128 | 5 | 5d909e4b5f662905bf1be9c686bbddc3e87d2be9 | |
| ToppCell | wk_08-11-Mesenchymal-Chondrocyte-Resting_chondrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.81e-04 | 182 | 128 | 5 | 00a148b1e499bf16325491536d187d4dd6b70c06 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.81e-04 | 182 | 128 | 5 | e36766309c4d96a90d213ce37d3acef1029a3fdc | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l14|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.86e-04 | 183 | 128 | 5 | 6e5b39c0170d62eb7fdd411dcfff51ed176573d0 | |
| Computational | Genes in the cancer module 227. | 1.34e-04 | 15 | 74 | 3 | MODULE_227 | |
| Computational | Steroid hormone and heme metabolism. | 1.64e-04 | 16 | 74 | 3 | MODULE_505 | |
| Drug | acridine | 1.82e-08 | 81 | 128 | 8 | CID000009215 | |
| Drug | SN-38G | 4.03e-08 | 59 | 128 | 7 | CID000443154 | |
| Drug | C1 11-32 | 4.19e-08 | 18 | 128 | 5 | CID000443077 | |
| Drug | C11131 | 4.19e-08 | 18 | 128 | 5 | CID000443076 | |
| Drug | UDP-alpha-d-xylopyranose | 4.54e-08 | 60 | 128 | 7 | CID000001165 | |
| Drug | T4-G | 5.67e-08 | 19 | 128 | 5 | CID000152424 | |
| Drug | estriol-16-glucuronide | 9.83e-08 | 21 | 128 | 5 | CID000122281 | |
| Drug | estradiol-3-glucuronide | 1.61e-07 | 23 | 128 | 5 | CID000066651 | |
| Drug | salicylamide | 2.84e-07 | 48 | 128 | 6 | CID000005147 | |
| Drug | L-idaro-1,4-lactone | 4.60e-07 | 28 | 128 | 5 | CID000078997 | |
| Drug | 7-hydroxycoumarin glucuronide | 5.53e-07 | 29 | 128 | 5 | CID000125641 | |
| Drug | menthol | 6.05e-07 | 87 | 128 | 7 | CID000001254 | |
| Drug | chondroitin sulfate | ITGB1 NRP1 ACAN VCAN UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B28 TNFAIP6 PLG MMP16 AGRN | 6.12e-07 | 413 | 128 | 13 | CID000024766 |
| Drug | 4-methylumbelliferone | 8.23e-07 | 132 | 128 | 8 | CID003364573 | |
| Drug | AC1Q6OQG | 1.09e-06 | 33 | 128 | 5 | CID000009686 | |
| Drug | BP-3,6-quinol | 1.09e-06 | 33 | 128 | 5 | CID000119292 | |
| Drug | AC1NOWCJ | 1.47e-06 | 35 | 128 | 5 | CID005120112 | |
| Drug | 3-[(3S,5R,10S,13R,14S,17R)-3-[(2S,4R,5R,6S)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-14-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one | 1.47e-06 | 35 | 128 | 5 | CID010436171 | |
| Drug | estrone-3-glucuronide | 1.47e-06 | 35 | 128 | 5 | CID000115255 | |
| Drug | AC1L7AJI | UGT2A1 UGT2B4 UGT2B7 UGT2B10 PRKCI UGT2B28 TNFAIP6 TOP1MT PCDHGC3 TOP3A | 1.92e-06 | 256 | 128 | 10 | CID000003750 |
| Drug | l-borneol | 1.96e-06 | 37 | 128 | 5 | CID000010049 | |
| Drug | harmol | 2.92e-06 | 40 | 128 | 5 | CID000068094 | |
| Drug | testosterone glucuronide | 3.31e-06 | 41 | 128 | 5 | CID000108192 | |
| Drug | 2-AF | 3.31e-06 | 41 | 128 | 5 | CID000005800 | |
| Drug | 2-hydroxyestriol | 3.43e-06 | 6 | 128 | 3 | CID000014688 | |
| Drug | androsterone glucuronide | 4.21e-06 | 43 | 128 | 5 | CID000114833 | |
| Drug | 7,8-benzoquinoline | 4.21e-06 | 43 | 128 | 5 | CID000009191 | |
| Drug | al-Badry | 4.39e-06 | 165 | 128 | 8 | CID000004545 | |
| Drug | MS-222 | 4.73e-06 | 44 | 128 | 5 | CID000011400 | |
| Drug | glucosiduronate | 5.72e-06 | 171 | 128 | 8 | CID000000610 | |
| Drug | SN-38 | 9.78e-06 | 184 | 128 | 8 | CID000104842 | |
| Drug | AC1NQGK1 | 1.09e-05 | 52 | 128 | 5 | CID005195977 | |
| Drug | Hymecromone | 1.10e-05 | 25 | 128 | 4 | ctd:D006923 | |
| Drug | oxazepam | 1.20e-05 | 53 | 128 | 5 | CID000004616 | |
| Drug | butylated hydroxytoluene | 1.67e-05 | 143 | 128 | 7 | CID000031404 | |
| Drug | 7-methoxycoumarin | 1.72e-05 | 57 | 128 | 5 | CID000010748 | |
| Drug | phenolphthalein | 1.87e-05 | 58 | 128 | 5 | CID000004764 | |
| Drug | 1-naphthol | 1.94e-05 | 98 | 128 | 6 | CID000007005 | |
| Drug | UDP-N-acetylglucosamine | 1.99e-05 | 203 | 128 | 8 | CID000001167 | |
| Drug | trans-3'-hydroxycotinine | 2.03e-05 | 29 | 128 | 4 | CID000000414 | |
| Drug | urochloralic acid | 2.04e-05 | 59 | 128 | 5 | CID003036914 | |
| Drug | 4-hydroxybiphenyl | 2.04e-05 | 59 | 128 | 5 | CID000007103 | |
| Drug | 4-hydroxyestrone | 2.04e-05 | 59 | 128 | 5 | CID000018418 | |
| Drug | acetaminophen glucuronide | 2.04e-05 | 59 | 128 | 5 | CID000083944 | |
| Drug | 3-hydroxyandrostan-17-one | 2.43e-05 | 102 | 128 | 6 | CID000000225 | |
| Drug | 3-OHBaP | 2.81e-05 | 63 | 128 | 5 | CID000025890 | |
| Drug | Meldola | 4.08e-05 | 68 | 128 | 5 | CID000081507 | |
| Drug | methoxyresorufin | 4.37e-05 | 69 | 128 | 5 | CID000119220 | |
| Drug | S 16020-2 | 4.76e-05 | 13 | 128 | 3 | CID000177329 | |
| Drug | fibrates | 5.53e-05 | 118 | 128 | 6 | CID000002797 | |
| Drug | eugenol | 5.74e-05 | 73 | 128 | 5 | CID000003314 | |
| Drug | 2,2,2-trichloroethanol | 5.74e-05 | 73 | 128 | 5 | CID000008259 | |
| Drug | 2-methoxyestradiol | 5.81e-05 | 236 | 128 | 8 | CID000001573 | |
| Drug | 7-hydroxycoumarin | 6.54e-05 | 75 | 128 | 5 | CID005281426 | |
| Drug | 16-epiestriol | 7.42e-05 | 77 | 128 | 5 | CID000003269 | |
| Drug | benzyloxyresorufin | 7.89e-05 | 78 | 128 | 5 | CID000114982 | |
| Drug | AC1N8H7N | 7.89e-05 | 78 | 128 | 5 | CID004318740 | |
| Drug | hexobarbital | 8.32e-05 | 127 | 128 | 6 | CID000003608 | |
| Drug | perylenediimide | 9.37e-05 | 3 | 128 | 2 | CID000066475 | |
| Drug | chavibetol | 9.37e-05 | 3 | 128 | 2 | CID000596375 | |
| Drug | 2,2,5,5-tetramethylimidazolidin-4-one | 9.37e-05 | 3 | 128 | 2 | CID009812798 | |
| Drug | 5 alpha-dihydroaldosterone | 9.37e-05 | 3 | 128 | 2 | CID003036614 | |
| Drug | v 2182 | 9.37e-05 | 3 | 128 | 2 | CID000078632 | |
| Drug | plakinidine A | 9.37e-05 | 3 | 128 | 2 | CID005468016 | |
| Drug | N-ethylethylenediamine | 9.37e-05 | 3 | 128 | 2 | CID000066071 | |
| Drug | 5 alpha-androstane | 1.12e-04 | 84 | 128 | 5 | CID000094144 | |
| Drug | estradiol; Down 200; 0.01uM; PC3; HT_HG-U133A | 1.20e-04 | 195 | 128 | 7 | 5910_DN | |
| Drug | 5286656; Up 200; 50uM; MCF7; HT_HG-U133A_EA | 1.20e-04 | 195 | 128 | 7 | 889_UP | |
| Drug | Ethamsylate [2624-44-4]; Up 200; 15.2uM; MCF7; HT_HG-U133A | 1.24e-04 | 196 | 128 | 7 | 7335_UP | |
| Drug | 7-ethoxycoumarin | 1.26e-04 | 86 | 128 | 5 | CID000035703 | |
| Drug | Metaproterenol sulfate, orciprenaline sulfate [5874-97-5]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 1.28e-04 | 197 | 128 | 7 | 4831_UP | |
| Drug | Sulfasalazine [599-79-1]; Up 200; 10uM; MCF7; HT_HG-U133A | 1.32e-04 | 198 | 128 | 7 | 5446_UP | |
| Drug | rofecoxib; Up 200; 10uM; MCF7; HG-U133A | 1.32e-04 | 198 | 128 | 7 | 256_UP | |
| Drug | pentoxyresorufin | 1.33e-04 | 87 | 128 | 5 | CID000107683 | |
| Drug | fagaronine | 1.33e-04 | 18 | 128 | 3 | CID000040304 | |
| Drug | Pentetic acid [67-43-6]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 1.36e-04 | 199 | 128 | 7 | 5264_UP | |
| Drug | 4-aminobiphenyl | 1.73e-04 | 92 | 128 | 5 | CID000007102 | |
| Drug | p-nitroanisole | 1.73e-04 | 92 | 128 | 5 | CID000007485 | |
| Drug | 2-naphthol | 1.82e-04 | 93 | 128 | 5 | CID000008663 | |
| Drug | N'-nitrosoanatabine | 1.84e-04 | 20 | 128 | 3 | CID000051291 | |
| Drug | oxophoebine | 1.87e-04 | 4 | 128 | 2 | CID000159317 | |
| Drug | lauterine | 1.87e-04 | 4 | 128 | 2 | CID000073104 | |
| Drug | 4-hydroxymethyl-4',5'-benzopsoralen | 1.87e-04 | 4 | 128 | 2 | CID000147789 | |
| Drug | AC1O58I7 | 1.87e-04 | 4 | 128 | 2 | CID006453989 | |
| Drug | methylphenylcarbamate | 1.87e-04 | 4 | 128 | 2 | CID000017451 | |
| Drug | mitindomide | 1.87e-04 | 4 | 128 | 2 | CID000066362 | |
| Drug | 2-fluoro-dATP | 1.87e-04 | 4 | 128 | 2 | CID000126365 | |
| Drug | dioxazine | 1.87e-04 | 4 | 128 | 2 | CID011969523 | |
| Drug | 3-O-alpha-L-arabinopyranosyl-oleanolic acid | 1.87e-04 | 4 | 128 | 2 | CID000124369 | |
| Drug | 20,29-dihydrobetulinic acid | 1.87e-04 | 4 | 128 | 2 | CID000065319 | |
| Drug | tumulosic acid | 1.87e-04 | 4 | 128 | 2 | CID005322174 | |
| Drug | NSC 380271 | 1.87e-04 | 4 | 128 | 2 | CID000342690 | |
| Drug | BFNU | 1.87e-04 | 4 | 128 | 2 | CID000096886 | |
| Drug | indole-4,7-dione | 1.87e-04 | 4 | 128 | 2 | CID000152300 | |
| Drug | A-74932 | 1.87e-04 | 4 | 128 | 2 | CID000132825 | |
| Drug | 1-methylcyclopentanecarboxylic acid | 2.01e-04 | 95 | 128 | 5 | CID000138436 | |
| Drug | ethoxyresorufin | 2.01e-04 | 95 | 128 | 5 | CID000003294 | |
| Drug | DCNB | 2.01e-04 | 95 | 128 | 5 | CID000007443 | |
| Drug | Aroclor 1254 | 2.06e-04 | 213 | 128 | 7 | CID000040470 | |
| Drug | DB04103 | 2.21e-04 | 97 | 128 | 5 | CID004469987 | |
| Disease | plasma clozapine-to-N-desmethylclozapine ratio measurement | 5.55e-06 | 9 | 121 | 3 | EFO_0600040 | |
| Disease | Abnormality of the sense of smell, COVID-19 symptoms measurement, ageusia | 1.67e-05 | 2 | 121 | 2 | EFO_0600019, EFO_1001758, HP_0004408 | |
| Disease | asthma, response to diisocyanate | 1.05e-04 | 261 | 121 | 7 | EFO_0006995, MONDO_0004979 | |
| Disease | Insulinogenic index measurement | 1.65e-04 | 5 | 121 | 2 | EFO_0009961 | |
| Disease | stimulant use measurement | 2.04e-04 | 28 | 121 | 3 | EFO_0600076 | |
| Disease | vanillylmandelate (VMA) measurement | 3.46e-04 | 7 | 121 | 2 | EFO_0800119 | |
| Disease | malignant epithelial tumor of ovary | 4.00e-04 | 35 | 121 | 3 | MONDO_0018364 | |
| Disease | deoxycholic acid glucuronide measurement | 4.59e-04 | 8 | 121 | 2 | EFO_0800575 | |
| Disease | Hereditary Sensory Autonomic Neuropathy, Type 1 | 4.59e-04 | 8 | 121 | 2 | C0020071 | |
| Disease | neuroticism measurement, cognitive function measurement | 5.57e-04 | 566 | 121 | 9 | EFO_0007660, EFO_0008354 | |
| Disease | Tetralogy of Fallot | 7.35e-04 | 10 | 121 | 2 | HP_0001636 | |
| Disease | parental longevity | 1.01e-03 | 494 | 121 | 8 | EFO_0007796 | |
| Disease | intracranial aneurysm (is_implicated_in) | 1.07e-03 | 12 | 121 | 2 | DOID:10941 (is_implicated_in) | |
| Disease | X-19141 measurement | 1.26e-03 | 13 | 121 | 2 | EFO_0800799 | |
| Disease | optic disc size measurement | 1.60e-03 | 205 | 121 | 5 | EFO_0004832 | |
| Disease | testosterone measurement | UBR1 FMO3 BCORL1 ZNF316 UGT2A2 DLK1 VARS2 CHORDC1 UGT2A1 UGT2B4 UGT2B7 UGT2B10 TPH1 | 2.24e-03 | 1275 | 121 | 13 | EFO_0004908 |
| Disease | periodontitis | 2.30e-03 | 223 | 121 | 5 | EFO_0000649 | |
| Disease | phosphatidylcholine 36:4 measurement | 2.44e-03 | 18 | 121 | 2 | EFO_0010382 | |
| Disease | magnesium measurement | 2.55e-03 | 66 | 121 | 3 | EFO_0004845 | |
| Disease | Deep Vein Thrombosis | 3.33e-03 | 21 | 121 | 2 | C0149871 | |
| Disease | Venous Thrombosis | 3.33e-03 | 21 | 121 | 2 | C0042487 | |
| Disease | urinary metabolite measurement | 3.45e-03 | 245 | 121 | 5 | EFO_0005116 | |
| Disease | X-24947 measurement | 3.65e-03 | 22 | 121 | 2 | EFO_0800910 | |
| Disease | unipolar depression, bipolar disorder, schizophrenia, sex interaction measurement | 3.80e-03 | 76 | 121 | 3 | EFO_0003761, EFO_0008343, MONDO_0004985, MONDO_0005090 | |
| Disease | Immunologic Deficiency Syndromes | 3.99e-03 | 23 | 121 | 2 | C0021051 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CEDPGTPKFGYKVHD | 1211 | Q7Z408 | |
| CGQPPVVENAKTFGK | 3296 | P13611 | |
| FSGPHCEKGLVEKSA | 1851 | O00468 | |
| EKDGFACDLLHNPPG | 1641 | Q5H9F3 | |
| PKLKVCFAHGGGAFP | 216 | Q8TDX5 | |
| KDGSGFSCKRLHPDP | 1781 | Q8TDJ6 | |
| FPKGKVNKEEAPHDC | 126 | Q8IU60 | |
| DVDKLHPVCPAGTFK | 191 | Q9NVE4 | |
| KKDGPCVINGSPCQH | 126 | P80370 | |
| HPKCVGEYGPKNGAE | 81 | Q2M2E5 | |
| FDPNKHCGVLDPETK | 291 | Q9ULK2 | |
| KENFIPCSEPVKGTG | 321 | Q8NCD3 | |
| HPGLKAKENDENCGP | 71 | P49756 | |
| EAVDKGFPPLAGHCT | 321 | Q9Y5H5 | |
| VKTLGGDPEKVHPAC | 106 | P48200 | |
| IPESPKCHEGNGTFE | 471 | P05556 | |
| FPGGKCDPADQDVVH | 66 | Q8WV74 | |
| LKVTHPPVVGSDGFC | 761 | Q17RG1 | |
| KCPGGFSQHPALISD | 556 | Q2M385 | |
| EAVDKGFPPLAGHCT | 321 | Q9UN72 | |
| APEKAENPAGHGSKE | 111 | Q9Y2S7 | |
| SIKGGPFKGCFHVPR | 381 | P51606 | |
| PKERLGCHPQTGFAD | 501 | P41743 | |
| PKESFPGLNHFKGKC | 156 | P31513 | |
| NPGEALPHICKAGEF | 836 | Q9NZR2 | |
| GPKEEQKCPSVHGQK | 611 | Q86W26 | |
| DPVRGPDGKTHGNKC | 651 | Q9NQ38 | |
| IRPGDPQHTKKFCFD | 511 | Q86SR1 | |
| KHPVSCKDTPGFIVN | 206 | Q16836 | |
| GAVKLPASGVKTHCP | 366 | Q6UXG2 | |
| TGGCSPKTKPHIKEE | 471 | Q8N6G6 | |
| KKFEIPVCPHAGGVG | 346 | Q7L5Y1 | |
| EEKPCGFPHVENGRI | 21 | P05160 | |
| KCFEGNPSHSQKEGL | 536 | Q9P2D6 | |
| PANKAPEESKGSAGC | 226 | O15018 | |
| GVHGPKTPCEEVYVK | 2671 | Q14315 | |
| FCPDQHGPKEQGPKH | 66 | A2RU54 | |
| KLPHKDGNSCNVGSP | 751 | P54098 | |
| GEVCRKKQPGQDCPH | 441 | Q12986 | |
| KPRCLHLEKGPQGFG | 326 | Q86UT5 | |
| HAKLQAPGSECLGPK | 811 | O95259 | |
| SGSCQKGPVPAIHKA | 206 | Q8N3J3 | |
| SKGEHVPGFCLPKKG | 2246 | Q92616 | |
| AKSHEKQPFDPICTG | 411 | Q9H0R1 | |
| DKGANPEGAHCKVLV | 326 | Q9UN70 | |
| ACSENPPAGIAHKGK | 1146 | A2RRP1 | |
| KKGTVACGEPPVVEH | 2441 | P16112 | |
| KPGHYIKNCPTNGDK | 166 | Q7Z6E9 | |
| KHCLPEGAPHRVNGK | 521 | Q14112 | |
| NGHFRGKFCGKIAPP | 96 | O14786 | |
| GTIFLPGNKVSEHPC | 61 | Q8N264 | |
| ANGQVKPCDFPDIKH | 16 | Q02985 | |
| KPCDFPDIKHGGLFH | 21 | Q02985 | |
| LSQPCGKIFVGDPHQ | 661 | Q8NFZ0 | |
| HPGLKVATNPNFDGK | 271 | Q8WXF7 | |
| GENGFNPDFCKKHPD | 1046 | P54132 | |
| HKPGCEKPGNEARGS | 326 | Q6E0U4 | |
| SKNECGILADPKGPF | 1061 | Q9Y6R7 | |
| GVHPAFALEKPGKCT | 4041 | Q8N3K9 | |
| LCFGEEDPGPTQHPK | 221 | Q9H1R2 | |
| HTGEKPFPCLECGKF | 436 | Q96SL8 | |
| DGFVKPGAHVKPGET | 501 | Q6MZM0 | |
| RKKPLSNCIHPGFTG | 6581 | Q8NDH2 | |
| PGFTIGAICKRENPH | 106 | P08397 | |
| NKCSFLHPEPVVGSK | 261 | Q6UWU4 | |
| PGGSADGKPKNFTCE | 266 | Q8TBJ5 | |
| KKCHSEPDGPGIAAL | 226 | Q9UKG9 | |
| QKCNPHPEDEQGKAG | 686 | A6NGG8 | |
| SPRGVHIPNCDKKGF | 231 | P17936 | |
| AQKKDFPHGIPECGT | 701 | Q5ST30 | |
| SKPHGTVKAICIPEG | 361 | Q6PI48 | |
| FDPKGHKVPCVGLSI | 371 | P49590 | |
| CESGHLKPGSKGPIF | 301 | Q9NYW6 | |
| GPAPAGKEHRKQDAE | 131 | Q86WR7 | |
| KGKVVLPGFQAVHCP | 506 | Q96JF0 | |
| GPKGKQLEGTECPLH | 4641 | O75592 | |
| AAPSFDCGKPQVEPK | 561 | P00747 | |
| PHNCGKQPAKFGTIC | 511 | Q4LDE5 | |
| EDHKPGTFPKALTNG | 811 | Q96QB1 | |
| SGPPSHKTVVNGKEC | 86 | O15269 | |
| VEPGFVPNKGRLHCD | 366 | Q86UX6 | |
| GKEKPQIICYPGTGH | 346 | Q8N9L9 | |
| CIAGFHPNPEGSQKD | 296 | Q14246 | |
| DVCHIAFGSKVLGPP | 131 | Q6ZVT6 | |
| FGFHKGKPESCAVTP | 2091 | Q8N3C0 | |
| IVGCTKGRHNSEKPP | 56 | Q9UHD1 | |
| EQPPCGVGKHKLEEG | 86 | Q15170 | |
| SGHAKVKPFDPKITC | 346 | P17752 | |
| GVHTFCDRQKPLPDG | 231 | Q8N5D0 | |
| QSHDKLRPFGCPAEG | 326 | P98169 | |
| HAKECGGVFTDPKQI | 131 | P98066 | |
| HLQGKPVCSFDPEGL | 146 | Q6UXN9 | |
| KGIPESPQGAFVHKE | 481 | P51512 | |
| CGSPQKLIDGFLKHE | 1106 | Q9UBZ9 | |
| KGKDELGVLPCQHAF | 101 | Q9H9V4 | |
| LPNVEFVGGLHCKPA | 271 | P06133 | |
| VPEASGPQNDGKKLC | 126 | Q7RTT6 | |
| SGSFHCGQQPEKKDL | 681 | Q6IQ55 | |
| PPELCHGIQGKFSLD | 711 | Q9H0D6 | |
| SCHQGIPGVLFPKKG | 1086 | Q6ZT07 | |
| TPGKVCRAEEGKSPF | 746 | O15014 | |
| GHQEKIGNFKIEPPG | 181 | Q969P6 | |
| PFCVNHEPGRAGTIK | 161 | Q8IWV7 | |
| QKEVGKGCDPDAHPK | 821 | Q9Y4E1 | |
| KGCDPDAHPKSTGVF | 826 | Q9Y4E1 | |
| DGPNKGRQFHTCAKP | 911 | Q13472 | |
| PKVAEEAVGGPQSCK | 56 | Q0VFX4 | |
| HTGQKPFACPECGKF | 546 | Q06730 | |
| PGEKPHKCNVCGRAF | 426 | Q86XU0 | |
| KGIEGHSPGNLPKFC | 286 | Q96GY0 | |
| AEEKPHRCPDCGKGF | 826 | A6NFI3 | |
| CDPKPVEFQGHQVKG | 931 | Q86YA3 | |
| PNVDFVGGLHCKPAK | 271 | P36537 | |
| IHTGEKPFACPECGK | 131 | Q9Y2P0 | |
| CPENPHKGKTDEFRK | 951 | Q63HK3 | |
| SHCGRKAPPGEECKQ | 161 | Q68EA5 | |
| LHFSPGAKGCEEDKN | 891 | O43314 | |
| DVPKAGAQPTKHGSC | 56 | Q64LD2 | |
| CGIKPASFEKVHDPE | 411 | Q9Y3S1 | |
| LPNIDFVGGLHCKPA | 271 | Q9BY64 | |
| KVKSGHPPETCPFFE | 311 | Q8IWY8 | |
| LPNVDFVGGLHCKPA | 271 | P16662 | |
| KPQCSEHGKASDEKP | 356 | Q2M3X9 | |
| QEIHPECGPCKTKKG | 311 | Q12789 | |
| FEFVGGLHCKPAKPL | 316 | P0DTE4 | |
| GHIASDCKFQRPGDP | 286 | Q15637 | |
| DYSCLKPPKAGEEGH | 751 | Q63HR2 | |
| KPPKAGEEGHEGCSY | 756 | Q63HR2 | |
| SGEEPHKCPECGKRF | 346 | Q6P9G9 | |
| FEFVGGLHCKPAKPL | 281 | P0DTE5 | |
| APHQSCSDGKFGIKP | 86 | P51508 | |
| GHYIKDCPQARPKGE | 141 | Q8N2G6 | |
| KVEEGGRHPSPCQFT | 3121 | O14686 | |
| GHVAKLPQKEPVGCS | 791 | Q9P206 | |
| FHCVGGSVQDPEKIP | 466 | P16519 |